This could be due to differences in  regulation of the S100 cluster in mice and humans, and may also result from common binding sites of MITF and TFE3 genome-wide, as seen for other neural and melanocytic markers that are occasionally positive in ASPS tumors. Here, MITF is linked to alveolar soft part sarcoma.